Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference

Rhea-AI Summary

Alamar Biosciences (Nasdaq: ALMR) will present at the BofA Securities 2026 Healthcare Conference in Las Vegas on Tuesday, May 12, 2026 at 3:40 p.m. PT / 6:40 p.m. ET. A live and archived webcast will be available in the Investors section at investors.alamarbio.com.

News Market Reaction – ALMR

-0.25%

-0.25% Session close to close

In the May 6 session, ALMR declined 0.25%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement centers on Alamar Biosciences’ participation in a major healthcare conference, wit...

Analysis

This announcement centers on Alamar Biosciences’ participation in a major healthcare conference, with management presenting on May 12 and providing a webcast via its investor site. It follows the company’s recent NASDAQ listing at $17 per share and an opening price of $22.6, plus evidence of commercial traction for its ARGO HT platform across >100 systems in 25 countries. Investors may watch for any new disclosures or strategic updates shared during the presentation.

Key Figures

Conference year: 2026 Presentation date: May 12 Presentation time PT: 3:40 p.m. +1 more

4 metrics

Conference year 2026 BofA Securities 2026 Healthcare Conference

Presentation date May 12 Scheduled conference presentation date

Presentation time PT 3:40 p.m. Scheduled presentation time Pacific Time

Presentation time ET 6:40 p.m. Scheduled presentation time Eastern Time

Historical Context

1 past event · Latest: 2026-04-20 (Positive)

Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
2026-04-20	NASDAQ listing	Positive	+0.0%	Initial NASDAQ listing with IPO pricing and commercial traction details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited history: the only prior tracked event (NASDAQ listing) showed no notable next-day move despite clearly positive fundamentals.

Recent Company History

Alamar Biosciences recently listed on NASDAQ, completing its IPO on April 17, 2026 with shares issued at $17 and opening at $22.6, implying a market cap near $1.5 billion. The company commercializes its NULISA™ and ARGO™ HT platforms, with ARGO HT exceeding 100 installed systems serving over 300 customers in 25 countries by end-2025. That listing news saw a flat 0% recorded 24-hour reaction, providing a single reference point as the company now announces participation in a major healthcare conference.

Key Terms

nasdaq

1 terms

nasdaq financial

"Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics..."

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FREMONT, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will be participating in the upcoming BofA Securities 2026 Healthcare Conference in Las Vegas, Nevada.

Alamar Biosciences’ management is scheduled to present on Tuesday, May 12, at 3:40 p.m. Pacific Time / 6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the session on the “Investors” section of the company website at investors.alamarbio.com.

About Alamar Biosciences, Inc.

Alamar is a life sciences company dedicated to powering Precision Proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar’s platform is designed to detect biomarkers with ultra-high sensitivity and address key limitations of existing technologies, helping researchers unlock the full spectrum of protein biomarkers across disease states.

Investor contact:

investors@alamarbio.com

Media contact:

media@alamarbio.com

FAQ

When will Alamar Biosciences (ALMR) present at the BofA Securities 2026 Healthcare Conference?

Alamar Biosciences will present on Tuesday, May 12, 2026 at 3:40 p.m. PT / 6:40 p.m. ET. According to Alamar Biosciences, management is scheduled for that session and will make the presentation in Las Vegas.

How can investors watch the ALMR presentation from the BofA 2026 Healthcare Conference?

Investors can access a live and archived webcast via the company investor site at investors.alamarbio.com. According to Alamar Biosciences, the webcast will be posted in the Investors section for live viewing and later replay.

What topics will Alamar Biosciences (ALMR) cover in its BofA 2026 Healthcare Conference presentation?

The company will present on its business and progress in precision proteomics during the conference session. According to Alamar Biosciences, management will discuss company developments relevant to early disease detection and investor interests.

Where and when is the BofA Securities 2026 Healthcare Conference taking place for ALMR attendees?

The conference is in Las Vegas, Nevada during BofA Securities' 2026 Healthcare event; Alamar presents May 12, 2026. According to Alamar Biosciences, the session time is 3:40 p.m. PT / 6:40 p.m. ET.

Will the ALMR presentation at BofA 2026 be available after the live session?

Yes, the presentation will be archived for later viewing on the company's investor website. According to Alamar Biosciences, a replay will be posted in the Investors section following the live webcast.